Principles of and strategies for germline gene therapy

Don P. Wolf, Paul A. Mitalipov, Shoukhrat Mitalipov

    Research output: Contribution to journalReview article

    1 Citation (Scopus)

    Abstract

    Monogenic disorders occur at a high frequency in human populations and are commonly inherited through the germline. Unfortunately, once the mutation has been transmitted to a child, only limited treatment options are available in most cases. However, means of correcting disease-causing nuclear and mitochondrial DNA mutations in gametes or preimplantation embryos have now been developed and are commonly referred to as germline gene therapy (GGT). We will discuss these novel strategies and provide a path forward for safe, high-efficiency GGT that may provide a promising new paradigm for preventing the passage of deleterious genes from parent to child.

    Original languageEnglish (US)
    JournalNature medicine
    DOIs
    StatePublished - Jan 1 2019

    Fingerprint

    Gene therapy
    Genetic Therapy
    Mutation
    Blastocyst
    Mitochondrial DNA
    Germ Cells
    Genes
    Population
    Therapeutics

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology(all)

    Cite this

    Principles of and strategies for germline gene therapy. / Wolf, Don P.; Mitalipov, Paul A.; Mitalipov, Shoukhrat.

    In: Nature medicine, 01.01.2019.

    Research output: Contribution to journalReview article

    @article{2f09757e69c643749810c71a3c22139f,
    title = "Principles of and strategies for germline gene therapy",
    abstract = "Monogenic disorders occur at a high frequency in human populations and are commonly inherited through the germline. Unfortunately, once the mutation has been transmitted to a child, only limited treatment options are available in most cases. However, means of correcting disease-causing nuclear and mitochondrial DNA mutations in gametes or preimplantation embryos have now been developed and are commonly referred to as germline gene therapy (GGT). We will discuss these novel strategies and provide a path forward for safe, high-efficiency GGT that may provide a promising new paradigm for preventing the passage of deleterious genes from parent to child.",
    author = "Wolf, {Don P.} and Mitalipov, {Paul A.} and Shoukhrat Mitalipov",
    year = "2019",
    month = "1",
    day = "1",
    doi = "10.1038/s41591-019-0473-8",
    language = "English (US)",
    journal = "Nature Medicine",
    issn = "1078-8956",
    publisher = "Nature Publishing Group",

    }

    TY - JOUR

    T1 - Principles of and strategies for germline gene therapy

    AU - Wolf, Don P.

    AU - Mitalipov, Paul A.

    AU - Mitalipov, Shoukhrat

    PY - 2019/1/1

    Y1 - 2019/1/1

    N2 - Monogenic disorders occur at a high frequency in human populations and are commonly inherited through the germline. Unfortunately, once the mutation has been transmitted to a child, only limited treatment options are available in most cases. However, means of correcting disease-causing nuclear and mitochondrial DNA mutations in gametes or preimplantation embryos have now been developed and are commonly referred to as germline gene therapy (GGT). We will discuss these novel strategies and provide a path forward for safe, high-efficiency GGT that may provide a promising new paradigm for preventing the passage of deleterious genes from parent to child.

    AB - Monogenic disorders occur at a high frequency in human populations and are commonly inherited through the germline. Unfortunately, once the mutation has been transmitted to a child, only limited treatment options are available in most cases. However, means of correcting disease-causing nuclear and mitochondrial DNA mutations in gametes or preimplantation embryos have now been developed and are commonly referred to as germline gene therapy (GGT). We will discuss these novel strategies and provide a path forward for safe, high-efficiency GGT that may provide a promising new paradigm for preventing the passage of deleterious genes from parent to child.

    UR - http://www.scopus.com/inward/record.url?scp=85067034600&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85067034600&partnerID=8YFLogxK

    U2 - 10.1038/s41591-019-0473-8

    DO - 10.1038/s41591-019-0473-8

    M3 - Review article

    JO - Nature Medicine

    JF - Nature Medicine

    SN - 1078-8956

    ER -